Investigational drug · Phase 2
ROC-101
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease.
Phase 2Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "ROC-101"
First trial start
2025
Oct 1, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "ROC-101", any sponsor or status.
Conditions studied
As listed on its trial records.
- Pulmonary Arterial Hypertension (PAH)
- Pulmonary Hypertension, Interstitial Lung Disease
Approved drugs for the same conditions: High blood pressure (hypertension) · Pulmonary arterial hypertension · Cardiovascular and metabolic · Respiratory
Largest trials
Live from ClinicalTrials.gov: studies naming "ROC-101" as an intervention, largest first.
AllRock Bio, Inc.Industry
NCT07175038 · 40 participants (planned) · Start Oct 1, 2025 · Primary completion Mar 2027
Drug: ROC-101 · For: Pulmonary Arterial Hypertension (PAH); Pulmonary Hypertension, Interstitial Lung Disease
Sites: Phoenix, Arizona; Rancho Cordova, California; Aurora, Colorado · 25 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Pharmacological profile and therapeutic evaluation of ROC-101, a potent and selective ROCK inhibitor, in arterial hypertension and pulmonary fibrosis.
Mo R, Lucas S, Feng XJ, et al. · Pharmacol Res 2026
- Antifertility activity of an indigenous plant preparation (ROC-101). 3. Effect on ultrastructure of the rat uterine luminal epithelium.
Munshi SR, Ljungkvist I · Indian J Med Res 1972
- Antifertility activity of an indigenous plant preparation (ROC-101). II. Effect on the male reproductive system.
Hunshi SR, Purandare TV, Ratnavally T, et al. · Indian J Med Res 1972
- Antifertility activity of an indigenous plant preparation (ROC-101). I. Effect on reproduction.
Munshi SR, Rao SS · Indian J Med Res 1972
Also in development for Pulmonary Arterial Hypertension (PAH)
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.